These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1817 related articles for article (PubMed ID: 22437871)

  • 1. Cancer immunotherapy via dendritic cells.
    Palucka K; Banchereau J
    Nat Rev Cancer; 2012 Mar; 12(4):265-77. PubMed ID: 22437871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.
    Burdin N; Moingeon P
    Cell Biol Toxicol; 2001; 17(2):67-75. PubMed ID: 11499697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
    Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM
    J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
    Kalinski P; Edington H; Zeh HJ; Okada H; Butterfield LH; Kirkwood JM; Bartlett DL
    Immunol Res; 2011 Aug; 50(2-3):235-47. PubMed ID: 21717071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
    Salem ML
    Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ; de Vries IJ; Torensma R; Figdor CG
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
    Morisaki T; Matsumoto K; Onishi H; Kuroki H; Baba E; Tasaki A; Kubo M; Nakamura M; Inaba S; Yamaguchi K; Tanaka M; Katano M
    Hum Cell; 2003 Dec; 16(4):175-82. PubMed ID: 15147037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.
    Schettini J; Mukherjee P
    Clin Dev Immunol; 2008; 2008():106321. PubMed ID: 19190769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of dendritic cells in cancer immunotherapy.
    Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA pulsed dendritic cells: an approach for cancer immunotherapy.
    Garg NK; Dwivedi P; Prabha P; Tyagi RK
    Vaccine; 2013 Feb; 31(8):1141-56. PubMed ID: 23306369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
    Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.
    Chen YZ; Yao XL; Tabata Y; Nakagawa S; Gao JQ
    Clin Dev Immunol; 2010; 2010():565643. PubMed ID: 21197274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial watch: anticancer vaccination with dendritic cells.
    Borges F; Laureano RS; Vanmeerbeek I; Sprooten J; Demeulenaere O; Govaerts J; Kinget L; Saraswat S; Beuselinck B; De Vleeschouwer S; Clement P; De Smet F; Sorg RV; Datsi A; Vigneron N; Naulaerts S; Garg AD
    Oncoimmunology; 2024; 13(1):2412876. PubMed ID: 39398476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.
    Nava S; Lisini D; Frigerio S; Bersano A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.